CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,764,000
- in 1 filing, $1.8M under 10b5-1 plans
Net −$1,764,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-15 | Grossman Adam S President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 780,950 | ||
| 2025-07-30 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Option exercise | +2,500 | $8.98 | $22K | 489,898 |
| 2025-07-30 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Shares withheld for taxes | −1,208 | $18.59 | $22K | 488,690 |
| 2025-07-30 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Option exercise · Employee Stock Option (right to buy) | −2,500 | 0 | ||
| 2025-07-24 | Kestenberg-Messina Kaitlin M. COO and SVP, Compliance | Shares withheld for taxes | −3,027 | $17.31 | $52K | 487,398 |
| 2025-07-24 | Tade Brad L. CFO and Treasurer | Shares withheld for taxes | −7,123 | $17.31 | $123K | 239,419 |
| 2025-07-15 | Grossman Adam S President and CEO | Option exercise 10b5-1 | +15,000 | $5.40 | $81K | 2,058,850 |
| 2025-07-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −15,000 | $18.66 | $280K | 2,043,850 |
| 2025-07-15 | Grossman Adam S President and CEO | Sale 10b5-1 | −6,000 | $18.66 | $112K | 2,037,850 |
| 2025-07-15 | Grossman Adam S President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 795,950 | ||
| 2025-06-26 | Tade Brad L. CFO and Treasurer | Shares withheld for taxes | −9,838 | $18.40 | $181K | 246,542 |
| 2025-06-16 | Grossman Adam S President and CEO | Option exercise 10b5-1 | +15,000 | $5.40 | $81K | 2,064,850 |
| 2025-06-16 | Grossman Adam S President and CEO | Sale 10b5-1 | −15,000 | $20.81 | $312K | 2,049,850 |
| 2025-06-16 | Grossman Adam S President and CEO | Sale 10b5-1 | −6,000 | $20.81 | $125K | 2,043,850 |
| 2025-06-16 | Grossman Adam S President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −15,000 | 810,950 | ||
| 2025-06-16 | ELMS STEVE Director | Sale | −194,749 | $20.24 | $3.9M | 87,330 |
| 2025-06-13 | ELMS STEVE Director | Option exercise | +9,000 | $5.96 | $54K | 96,330 |
| 2025-06-13 | ELMS STEVE Director | Option exercise | +10,000 | $5.00 | $50K | 106,330 |
| 2025-06-13 | ELMS STEVE Director | Option exercise | +53,837 | $3.66 | $197K | 160,167 |
| 2025-06-13 | ELMS STEVE Director | Option exercise | +17,500 | $4.91 | $86K | 177,667 |
Page 5 of 31 · 618 trades